Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology - Lindeman, N I; Cagle, P T; Beasley, M B (J Thorac Oncol, 2013)